EWTX

Edgewise Therapeutics, Inc.

Healthcare›Biotechnology|NASDAQ Global Select|US

Price

$33.33

Market Cap

$3.58B

Beta

0.27

P/E

0.0

Div Yield

—

Sector Median P/E

22.6

Key Metrics

Revenue Growth (YoY)+0.00%

EPS Growth (YoY)-12.41%

Revenue CAGR 3Y+0.00%

P/E Ratio0.0

PEG Ratio—

FCF Yield-4.02%

Debt / Equity0.01

Interest Coverage999.0x

No credit card required

Already have an account? Sign in to view the full analysis for EWTX.